nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer
|
Skolnik, Jeffrey M. |
|
2005 |
57 |
4 |
p. 458-464 |
artikel |
2 |
Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells
|
Lin, Yi-Hsien |
|
2005 |
57 |
4 |
p. 525-532 |
artikel |
3 |
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
|
Jermann, Monika |
|
2005 |
57 |
4 |
p. 533-539 |
artikel |
4 |
Apoptosis induced by glycoprotein (150-kDa) isolated from Solanum nigrum L. is not related to intracellular reactive oxygen species (ROS) in HCT-116 cells
|
Lee, Sei-Jung |
|
2005 |
57 |
4 |
p. 507-516 |
artikel |
5 |
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy
|
Latz, Jane E |
|
2005 |
57 |
4 |
p. 412-426 |
artikel |
6 |
Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells
|
Serova, Maria |
|
2005 |
57 |
4 |
p. 491-499 |
artikel |
7 |
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy
|
Latz, Jane E. |
|
2005 |
57 |
4 |
p. 427-435 |
artikel |
8 |
Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in children
|
Turner, P. Kellie |
|
2005 |
57 |
4 |
p. 475-482 |
artikel |
9 |
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells
|
Angela, Michelutti |
|
2005 |
57 |
4 |
p. 517-524 |
artikel |
10 |
Interpreting cell cycle effects of drugs: the case of melphalan
|
Lupi, Monica |
|
2005 |
57 |
4 |
p. 443-457 |
artikel |
11 |
Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer
|
Chedid, Silwan |
|
2005 |
57 |
4 |
p. 540-544 |
artikel |
12 |
Pharmacokinetics and phototoxicity of purpurin-18 in human colon carcinoma cells using liposomes as delivery vehicles
|
Sharma, Sulbha |
|
2005 |
57 |
4 |
p. 500-506 |
artikel |
13 |
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
|
Ramanathan, Ramesh K. |
|
2005 |
57 |
4 |
p. 465-474 |
artikel |
14 |
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma
|
Kim, Seok Jin |
|
2005 |
57 |
4 |
p. 436-442 |
artikel |
15 |
Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients
|
Latz, Jane E |
|
2005 |
57 |
4 |
p. 401-411 |
artikel |
16 |
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro
|
Carr, Jocelyn L |
|
2005 |
57 |
4 |
p. 483-490 |
artikel |